Baylor College of Medicine: all 747 studies

Page 8 of 8. Open to participants first (111), then studies with results posted, then the rest; newest registration first within each.

• Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone InvolvementCompletedNCT00206388Phase 1
• Ability to Cope With Type 1 DiabetesCompletedNCT00206362
• Ability to Cope With Type 1 DiabetesCompletedNCT00206349
• The Effect of Prolonged Pramlintide Infusion in Pediatric DiabetesCompletedNCT00206297Phase 3
• The Role of Amylin and Glucagon in T1DMCompletedNCT00206258Phase 3
• Novel Treatment for Diastolic Heart Failure in WomenCompletedNCT00206232Phase 4
• Physician Uncertainty Reduction for HypertensionCompletedNCT00201084Not applicable
• Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin AddictsCompletedNCT00142948Phase 2
• Study of Na-ASP-2 Human Hookworm Vaccine in Healthy Adults Without Evidence of Hookworm InfectionCompletedNCT00120081Phase 1
• Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma PatientsCompletedNCT00085930Phase 1
• LMP2a-Specific Cytotoxic T-Lymphocytes, Lymphoma (ACDAL)TerminatedNCT00082225Phase 1
• EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC)CompletedNCT00078546Phase 1
• Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell TransplantCompletedNCT00078533Phase 1
• Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor CellsCompletedNCT00078520Phase 1
• Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT GemcitabineTerminatedNCT00074607Phase 1
• Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell TransplantationCompletedNCT00073879Not applicable
• Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CMLTerminatedNCT00069992Phase 2
• Study of Antioxidants and Oxidants in Malnourished ChildrenCompletedNCT00069134Not applicable
• Intrathecal MafosfamideCompletedNCT00062881Phase 1
• Using Gene Modified Neuroblastoma Cells for the Treatment of Relapsed/Refractory NeuroblastomaCompletedNCT00062855Phase 1
• Study of Irinotecan on a Weekly Schedule in ChildrenCompletedNCT00062842Phase 1
• Valacyclovir in Immunocompromised ChildrenCompletedNCT00059592Phase 1
• Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients Who Have Had Donor Marrow GraftsCompletedNCT00058812Phase 1
• Treating High Risk Leukemia With CD40 Ligand & IL-2 Gene Modified Tumor VaccineCompletedNCT00058799Phase 1
• Treatment of Chronic Lymphocytic B-Leukemia With IL-2 and CD-40 Autologous Tumor CellsCompletedNCT00058786Phase 1
• Giving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin DiseaseTerminatedNCT00058773Phase 1
• Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells, Relapsed Lymphoma, ANGELCompletedNCT00058617Phase 1
• Prevention and Treatment of Epstein-Barr Virus (EBV) Lymphoma Following a Solid Organ Transplant Using EBV Specific Cytotoxic T Lymphocytes (CTLs).CompletedNCT00058604Phase 1
• Treating Severe Chronic Epstein-Barr Virus (EBV) Infection With EBV Specific Cytotoxic T Lymphocytes (CTLs)CompletedNCT00058591Phase 1
• Stem Cell Transplant to Treat Patients With Systemic SclerosisCompletedNCT00058578Phase 1
• Anti-Human CD45 Monoclonal Antibodies in Patients With Advanced Leukemia Prior to Allogeneic Stem Cell TransplantationCompletedNCT00057005Phase 1
• Monoclonal Antibody Conditioning for Allogeneic Stem Cell Transplantation of Patients With Inherited Metabolic Storage DiseasesTerminatedNCT00056979Phase 1/2
• Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological DiseasesCompletedNCT00056966Phase 1/2
• Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1HCompletedNCT00048412Phase 1/2
• Stem Cell Transplantation for Patients With Graft Failure Following an Allogeneic Transplant, Using Identical or Near Identical Donors and Less Toxic Conditioning With CAMPATH 1HTerminatedNCT00048399Phase 1/2
• Treatment of Resistant Langerhans Cell Histiocytosis With ENBRELCompletedNCT00048373Phase 2
• Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain TumorsCompletedNCT00042367Not applicable
• A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology PatientsCompletedNCT00042328Phase 2
• High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple SclerosisCompletedNCT00040482Phase 2
• Bone Marrow Transplant From Related Donor for Patients With High Risk HemoglobinopathiesTerminatedNCT00040469Phase 2
• Oral Magnesium Pidolate, Hemoglobin SC Disease, MG PidolateTerminatedNCT00040456Phase 2
• Bone Marrow Transplant From Donor Using Less Toxic Conditioning for Patient With High Risk HemoglobinopathiesTerminatedNCT00040417Phase 2
• Encouraging Calcium Absorption and Bone Formation During Early PubertyCompletedNCT00022867Phase 1/2
• Improving Hypertension Care for Inner City MinoritiesCompletedNCT00005707
• Delta Hepatitis and Liver Disease in HemophiliacsCompletedNCT00005304
• Low Fat Diet to Prevent Disease Progression in Patients With Skin CancerStatus unknownNCT00003097Phase 2
• Treatments for Benign Paroxysmal Positional Vertigo (BPPV)CompletedNCT00000359Phase 2

← Baylor College of Medicine overview and focus areas